Werfen completes acquisition of Immucor

Create PDF

Immucor is a privately held corporation with a global presence in transfusion and transplant in vitro diagnostics. Werfen says the acquisition will allow it to expand its portfolio of specialized diagnostics solutions for hospitals and clinical laboratories. The company will have seven technology centers, employ more than 7,000 people worldwide, and have a presence in more than 30 countries.